Cargando…
The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts
BACKGROUND: Opioids may have effects on susceptibility to HIV-infection, viral replication and disease progression. Injecting drug users (IDU), as well as anyone receiving opioids for anesthesia and analgesia may suffer the clinical consequences of such interactions. There is conflicting data betwee...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091651/ https://www.ncbi.nlm.nih.gov/pubmed/25013451 http://dx.doi.org/10.1186/1742-6405-11-17 |
_version_ | 1782480788190658560 |
---|---|
author | Prottengeier, Johannes Koutsilieri, Eleni Scheller, Carsten |
author_facet | Prottengeier, Johannes Koutsilieri, Eleni Scheller, Carsten |
author_sort | Prottengeier, Johannes |
collection | PubMed |
description | BACKGROUND: Opioids may have effects on susceptibility to HIV-infection, viral replication and disease progression. Injecting drug users (IDU), as well as anyone receiving opioids for anesthesia and analgesia may suffer the clinical consequences of such interactions. There is conflicting data between in vitro experiments showing an enhancing effect of opioids on HIV replication and clinical data, mostly showing no such effect. For clarification we studied the effects of the opioids heroin and morphine on HIV replication in cultured CD4-positive T cells at several concentrations and we related the observed effects with the relevant reached plasma concentrations found in IDUs. METHODS: Latently-infected ACH-2 T lymphoblasts were incubated with different concentrations of morphine and heroine. Reactivation of HIV was assessed by intracellular staining of viral Gag p24 protein and subsequent flow cytometric quantification of p24-positive cells. The influence of the opioid antagonist naloxone and the antioxidants N-acetyl-cysteine (NAC) and glutathione (GSH) on HIV reactivation was determined. Cell viability was investigated by 7-AAD staining and flow cytometric quantification. RESULTS: Morphine and heroine triggered reactivation of HIV replication in ACH-2 cells in a dose-dependent manner at concentrations above 1 mM (EC(50) morphine 2.82 mM; EC(50) morphine 1.96 mM). Naloxone did not interfere with heroine-mediated HIV reactivation, even at high concentrations (1 mM). Opioids also triggered necrotic cell death at similar concentrations at which HIV reactivation was observed. Both opioid-mediated reactivation of HIV and opioid-triggered cell death could be inhibited by the antioxidants GSH and NAC. CONCLUSIONS: Opioids reactivate HIV in vitro but at concentrations that are far above the plasma levels of analgesic regimes or drug concentrations found in IDUs. HIV reactivation was mediated by effects unrelated to opioid-receptor activation and was tightly linked to the cytotoxic activity of the substances at millimolar concentrations, suggesting that opioid-mediated reactivation of HIV was due to accompanying effects of cellular necrosis such as activation of reactive oxygen species and NF-κB. |
format | Online Article Text |
id | pubmed-4091651 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40916512014-07-11 The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts Prottengeier, Johannes Koutsilieri, Eleni Scheller, Carsten AIDS Res Ther Research BACKGROUND: Opioids may have effects on susceptibility to HIV-infection, viral replication and disease progression. Injecting drug users (IDU), as well as anyone receiving opioids for anesthesia and analgesia may suffer the clinical consequences of such interactions. There is conflicting data between in vitro experiments showing an enhancing effect of opioids on HIV replication and clinical data, mostly showing no such effect. For clarification we studied the effects of the opioids heroin and morphine on HIV replication in cultured CD4-positive T cells at several concentrations and we related the observed effects with the relevant reached plasma concentrations found in IDUs. METHODS: Latently-infected ACH-2 T lymphoblasts were incubated with different concentrations of morphine and heroine. Reactivation of HIV was assessed by intracellular staining of viral Gag p24 protein and subsequent flow cytometric quantification of p24-positive cells. The influence of the opioid antagonist naloxone and the antioxidants N-acetyl-cysteine (NAC) and glutathione (GSH) on HIV reactivation was determined. Cell viability was investigated by 7-AAD staining and flow cytometric quantification. RESULTS: Morphine and heroine triggered reactivation of HIV replication in ACH-2 cells in a dose-dependent manner at concentrations above 1 mM (EC(50) morphine 2.82 mM; EC(50) morphine 1.96 mM). Naloxone did not interfere with heroine-mediated HIV reactivation, even at high concentrations (1 mM). Opioids also triggered necrotic cell death at similar concentrations at which HIV reactivation was observed. Both opioid-mediated reactivation of HIV and opioid-triggered cell death could be inhibited by the antioxidants GSH and NAC. CONCLUSIONS: Opioids reactivate HIV in vitro but at concentrations that are far above the plasma levels of analgesic regimes or drug concentrations found in IDUs. HIV reactivation was mediated by effects unrelated to opioid-receptor activation and was tightly linked to the cytotoxic activity of the substances at millimolar concentrations, suggesting that opioid-mediated reactivation of HIV was due to accompanying effects of cellular necrosis such as activation of reactive oxygen species and NF-κB. BioMed Central 2014-07-02 /pmc/articles/PMC4091651/ /pubmed/25013451 http://dx.doi.org/10.1186/1742-6405-11-17 Text en Copyright © 2014 Prottengeier et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Prottengeier, Johannes Koutsilieri, Eleni Scheller, Carsten The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts |
title | The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts |
title_full | The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts |
title_fullStr | The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts |
title_full_unstemmed | The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts |
title_short | The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts |
title_sort | effects of opioids on hiv reactivation in latently-infected t-lymphoblasts |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091651/ https://www.ncbi.nlm.nih.gov/pubmed/25013451 http://dx.doi.org/10.1186/1742-6405-11-17 |
work_keys_str_mv | AT prottengeierjohannes theeffectsofopioidsonhivreactivationinlatentlyinfectedtlymphoblasts AT koutsilierieleni theeffectsofopioidsonhivreactivationinlatentlyinfectedtlymphoblasts AT schellercarsten theeffectsofopioidsonhivreactivationinlatentlyinfectedtlymphoblasts AT prottengeierjohannes effectsofopioidsonhivreactivationinlatentlyinfectedtlymphoblasts AT koutsilierieleni effectsofopioidsonhivreactivationinlatentlyinfectedtlymphoblasts AT schellercarsten effectsofopioidsonhivreactivationinlatentlyinfectedtlymphoblasts |